Concord Medical Services Files Routine 6-K Report

Ticker: CCM · Form: 6-K · Filed: Aug 29, 2024 · CIK: 1472072

Concord Medical Services Holdings Ltd 6-K Filing Summary
FieldDetail
CompanyConcord Medical Services Holdings Ltd (CCM)
Form Type6-K
Filed DateAug 29, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: reporting, 6-K, foreign-private-issuer

TL;DR

Concord Medical Services filed a 6-K, no new info, just routine reporting.

AI Summary

Concord Medical Services Holdings Limited filed a Form 6-K on August 29, 2024. The filing is a report of a foreign private issuer and does not contain specific financial details or operational updates beyond its routine nature. The company's principal executive office is located in Beijing, People's Republic of China.

Why It Matters

This filing indicates that Concord Medical Services is fulfilling its reporting obligations as a foreign private issuer, but it does not provide new material information for investors.

Risk Assessment

Risk Level: low — This is a routine filing that does not contain new material information or indicate any significant changes in the company's operations or financial status.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of August 2024.

Where is Concord Medical Services Holdings Limited's principal executive office located?

The company's principal executive office is located at Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020, People's Republic of China.

Does the registrant file annual reports under Form 20-F or Form 40-F?

The registrant indicates it files annual reports under cover of Form 20-F.

What is the Commission File Number for Concord Medical Services Holdings Limited?

The Commission File Number is 001-34563.

Does this filing contain specific financial results or operational updates?

The provided text of the filing does not contain specific financial results or operational updates; it appears to be a routine reporting document.

Filing Stats: 300 words · 1 min read · ~1 pages · Grade level 12.3 · Accepted 2024-08-29 16:03:23

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Republic of China (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Concord Healthcare Announces Interim Results on The Stock Exchange of Hong Kong Limited Concord Healthcare Group Co., Ltd. (“Concord Healthcare”), a subsidiary of Concord Medical Services Holdings Limited (the “Company”) (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKSE”) under the stock code 2453.HK, announced its interim results for the six months ended June 30, 2024 on August 29, 2024. The Company previously announced the listing of Concord Healthcare’s H shares on the HKSE on January 9, 2024. The information related to the announcement of Concord Healthcare’s interim results on the HKSE is accessible through the HKSE’s website at www.hkexnews.hk . SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CONCORD MEDICAL SERVICES HOLDINGS LIMITED By: /s/ Jianyu Yang Name: Jianyu Yang Title: Chairman and Chief Executive Officer Date: August 29, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing